Newman Dignan & Sheerar, Inc. Incyte Corp Transaction History
Newman Dignan & Sheerar, Inc.
- $585 Million
- Q3 2024
A detailed history of Newman Dignan & Sheerar, Inc. transactions in Incyte Corp stock. As of the latest transaction made, Newman Dignan & Sheerar, Inc. holds 5,022 shares of INCY stock, worth $361,232. This represents 0.06% of its overall portfolio holdings.
Number of Shares
5,022
Previous 4,442
13.06%
Holding current value
$361,232
Previous $269,000
23.05%
% of portfolio
0.06%
Previous 0.07%
Shares
3 transactions
Others Institutions Holding INCY
# of Institutions
649Shares Held
186MCall Options Held
714KPut Options Held
557K-
Baker Bros. Advisors LP New York, NY30.7MShares$2.21 Billion21.76% of portfolio
-
Black Rock Inc. New York, NY21.4MShares$1.54 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA20.4MShares$1.47 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA15.3MShares$1.1 Billion0.61% of portfolio
-
State Street Corp Boston, MA10.6MShares$759 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $16B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...